List of Treatments for COPD

Advair (Fluticasone/Salmeterol)

Overview
Advair is a prescription drug approved by the Food and Drug Administration (FDA) as maintenance treatment for chronic obstructive pulmonary disease (COPD). Advair is a combination drug composed of Fluticasone… read more

AirDuo RespiClick (Fluticasone/Salmeterol)

Overview
AirDuo RespiClick is a prescription drug approved by the Food and Drug Administration (FDA) to treat asthma in people age 12 years and older. AirDuo RespiClick may be prescribed off-label in cases of chronic… read more

Alvesco (Ciclesonide)

Overview
Alvesco is a prescription drug approved by the Food and Drug Administration (FDA) in 2008 for maintenance treatment of asthma in people 12 years of age and older. In chronic obstructive pulmonary disease… read more

Anoro Ellipta (Umeclidinium/Vilanterol)

Overview
Anoro Ellipta is a prescription drug approved by the Food and Drug Administration (FDA) as long-term, once-daily maintenance treatment for airflow obstruction in people with chronic obstructive pulmonary… read more

Antibiotics

Overview
Antibiotics are medications that kill or inhibit the growth of microorganisms such as bacteria or fungi. Antibiotics work by attacking the source of the infection. Antibiotics may be prescribed in some cases of… read more

Aralast NP (Alpha1-proteinase inhibitor [human])

Overview
Aralast NP is a prescription drug approved by the Food and Drug Administration (FDA) as maintenance therapy in adults who have clinically evident emphysema due to Alpha-1 antitrypsin (AAT) deficiency, a rare… read more

Arcapta Neohaler (Indacaterol maleate)

Overview

Arcapta is a prescription drug approved by the Food and Drug Administration (FDA) in 2011 for maintenance treatment of airflow obstruction in chronic obstructive pulmonary disease (COPD). Arcapta is not… read more

Arnuity Ellipta (Fluticasone furoate)

Overview

Arnuity Ellipta is a prescription drug approved by the Food and Drug Administration (FDA) in 2014 for maintenance treatment of asthma and chronic obstructive pulmonary disease (COPD). Arnuity Ellipta is not… read more

Asmanex (Mometasone)

Overview
Asmanex is a prescription drug approved by the Food and Drug Administration (FDA) in 2005 for maintenance treatment of asthma. Asmanex is indicated for use in people four years of age and older. Asmanex is used… read more

Atrovent (Ipratropium bromide)

Overview
Atrovent is a prescription drug approved by the Food and Drug Administration (FDA) for the maintenance treatment of bronchospasms caused by asthma, allergies, chronic obstructive pulmonary disease (COPD), and… read more

Bevespi Aerosphere (Glycopyrrolate/Formoterol fumarate)

Overview
Bevespi Aerosphere is a prescription drug approved by the Food and Drug Administration (FDA) as long-term maintenance treatment for airflow obstruction in people with chronic obstructive pulmonary disease… read more

Breo Ellipta (Fluticasone/Vilanterol)

Overview

Breo Ellipta is a prescription drug approved by the Food and Drug Administration (FDA) in 2013 for daily maintenance treatment in cases of chronic obstructive pulmonary disease (COPD). Breo Ellipta helps… read more

Breztri (Budesonide, Glycopyrrolate, and Formoterol fumarate)

Overview
Breztri is a prescription drug approved by the U.S. Food and Drug Administration (FDA) as long-term, daily maintenance treatment for airflow obstruction in people with chronic obstructive pulmonary disease… read more

Brovana (Arformoterol)

Overview

Brovana is a prescription drug first approved by the Food and Drug Administration (FDA) for long-term maintenance of bronchoconstriction in chronic obstructive pulmonary disease (COPD). Brovana is not… read more

Bullectomy

Overview

In people with chronic obstructive pulmonary disease (COPD), the structure of the lung weakens. The alveoli, tiny sacs of air where carbon dioxide is exchanged for oxygen, may become damaged. If the alveoli… read more

Combivent Respimat (Ipratropium bromide/Albuterol)

Overview
Combivent Respimat is a prescription drug approved by the Food and Drug Administration (FDA) in 2011 to prevent bronchospasm in people with chronic obstructive pulmonary disease (COPD). Combivent Respimat is… read more

Daliresp (Roflumilast)

Overview
Daliresp is a prescription drug approved by the Food and Drug Administration (FDA) to reduce the risk of exacerbations in people with chronic obstructive pulmonary disease (COPD), chronic bronchitis, and a… read more

Duaklir Pressair (Aclidinium bromide/Formoterol fumarate)

Overview
Duaklir Pressair is a prescription drug approved by the Food and Drug Administration (FDA) as long-term maintenance treatment for airflow obstruction in people with chronic obstructive pulmonary disease… read more

Dulera (Mometasone/Formoterol)

Overview
Dulera is a prescription drug approved by the Food and Drug Administration (FDA) in 2010 for maintenance treatment of asthma. Dulera helps prevent bronchospasm in chronic obstructive pulmonary disease (COPD).… read more

DuoNeb (Ipratropium/Albuterol)

Overview
DuoNeb is a prescription drug approved by the Food and Drug Administration (FDA) to treat bronchospasm in people with chronic obstructive pulmonary disease (COPD) who need more than one bronchodilator. DuoNeb… read more

Exercise

Overview

Even small amounts of physical activity can improve symptoms and promote general health in people with any stage of chronic obstructive pulmonary disease (COPD). Aerobic exercise keeps your heart healthy.… read more

Fasenra (Benralizumab)

Overview
Fasenra is a prescription medication approved by the Food and Drug Administration (FDA) to treat severe asthma in people age 12 and older. Fasenra may be prescribed in cases of asthma that test positive for an… read more

Flu shots

Overview
People with chronic obstructive pulmonary disease (COPD) are at greater risk for serious complications from influenza (the flu), such as pneumonia. It is important to protect yourself by receiving a flu shot… read more

Foradil (Formoterol)

Overview
Foradil is a prescription drug first approved by the Food and Drug Administration (FDA) in 2001 for maintenance of asthma and prevention of bronchospasms in chronic obstructive pulmonary disease (COPD). Foradil… read more

Glassia (Alpha1-proteinase inhibitor [human])

Overview
Glassia is a prescription drug approved by the Food and Drug Administration (FDA) as maintenance therapy in adults who have clinically evident emphysema due to Alpha-1 antitrypsin deficiency, a rare genetic… read more

Incruse Ellipta (Umeclidinium bromide)

Overview
Incruse Ellipta is a prescription drug approved by the Food and Drug Administration (FDA) for long-term, once-daily maintenance treatment of airflow obstruction in people with chronic obstructive pulmonary… read more

Lonhala Magnair (Glycopyrrolate)

Overview
Lonhala Magnair is a prescription drug approved by the Food and Drug Administration (FDA) as long-term maintenance treatment for airflow obstruction in people with chronic obstructive pulmonary disease (COPD).… read more

Lung transplant

Overview
Lung transplant may be an option for some people with end-stage chronic obstructive pulmonary disease (COPD) who have tried every other avenue of treatment. Lung transplants may involve one (single-lung… read more

Lung volume reduction surgery

Overview

Lung volume reduction surgery is an option for some people with severe, advanced emphysema, a type of chronic obstructive pulmonary disease (COPD). In these people, the lungs are hyperinflated and cannot… read more

Mucinex (Guaifenesin)

Overview

Mucinex, also known by its drug name, Guaifenesin, is an over-the-counter medication used to relieve coughs and chest congestion associated with cold and flu. Some physicians recommend Mucinex to help treat… read more